EMEA (Europe, Middle East and Africa) Trastuzumab Market Report 2017

October 2017 | 102 pages | ID: E6595BA4A84PEN
QYResearch

Abstracts

In this report, the EMEA Trastuzumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Trastuzumab for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Trastuzumab market competition by top manufacturers/players, with Trastuzumab sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Genentech Inc
• Novartis AG
• Pfizer
• Abnova Corporation
• InvivoGen
• Celltrion
• Biocon Limited
• Bio-Techne

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Human Source
• Animal Source

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Trastuzumab for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Trastuzumab Market Report 2017

1 TRASTUZUMAB OVERVIEW

1.1 Product Overview and Scope of Trastuzumab
1.2 Classification of Trastuzumab
  1.2.1 EMEA Trastuzumab Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Trastuzumab Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Human Source
  1.2.4 Animal Source
1.3 EMEA Trastuzumab Market by Application/End Users
  1.3.1 EMEA Trastuzumab Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 EMEA Trastuzumab Market by Region
  1.4.1 EMEA Trastuzumab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Trastuzumab (2012-2022)
  1.5.1 EMEA Trastuzumab Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Trastuzumab Revenue and Growth Rate (2012-2022)

2 EMEA TRASTUZUMAB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Trastuzumab Market Competition by Players/Manufacturers
  2.1.1 EMEA Trastuzumab Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Trastuzumab Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Trastuzumab Sale Price by Players (2012-2017)
2.2 EMEA Trastuzumab (Volume and Value) by Type/Product Category
  2.2.1 EMEA Trastuzumab Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Trastuzumab Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Trastuzumab Sale Price by Type (2012-2017)
2.3 EMEA Trastuzumab (Volume) by Application
2.4 EMEA Trastuzumab (Volume and Value) by Region
  2.4.1 EMEA Trastuzumab Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Trastuzumab Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Trastuzumab Sales Price by Region (2012-2017)

3 EUROPE TRASTUZUMAB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Trastuzumab Sales and Value (2012-2017)
  3.1.1 Europe Trastuzumab Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Trastuzumab Revenue and Growth Rate (2012-2017)
3.2 Europe Trastuzumab Sales and Market Share by Type
3.3 Europe Trastuzumab Sales and Market Share by Application
3.4 Europe Trastuzumab Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Trastuzumab Sales Volume by Countries (2012-2017)
  3.4.2 Europe Trastuzumab Revenue by Countries (2012-2017)
  3.4.3 Germany Trastuzumab Sales and Growth Rate (2012-2017)
  3.4.4 France Trastuzumab Sales and Growth Rate (2012-2017)
  3.4.5 UK Trastuzumab Sales and Growth Rate (2012-2017)
  3.4.6 Russia Trastuzumab Sales and Growth Rate (2012-2017)
  3.4.7 Italy Trastuzumab Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Trastuzumab Sales and Growth Rate (2012-2017)

4 MIDDLE EAST TRASTUZUMAB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Trastuzumab Sales and Value (2012-2017)
  4.1.1 Middle East Trastuzumab Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Trastuzumab Revenue and Growth Rate (2012-2017)
4.2 Middle East Trastuzumab Sales and Market Share by Type
4.3 Middle East Trastuzumab Sales and Market Share by Application
4.4 Middle East Trastuzumab Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Trastuzumab Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Trastuzumab Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Trastuzumab Sales and Growth Rate (2012-2017)
  4.4.4 Israel Trastuzumab Sales and Growth Rate (2012-2017)
  4.4.5 UAE Trastuzumab Sales and Growth Rate (2012-2017)
  4.4.6 Iran Trastuzumab Sales and Growth Rate (2012-2017)

5 AFRICA TRASTUZUMAB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Trastuzumab Sales and Value (2012-2017)
  5.1.1 Africa Trastuzumab Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Trastuzumab Revenue and Growth Rate (2012-2017)
5.2 Africa Trastuzumab Sales and Market Share by Type
5.3 Africa Trastuzumab Sales and Market Share by Application
5.4 Africa Trastuzumab Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Trastuzumab Sales Volume by Countries (2012-2017)
  5.4.2 Africa Trastuzumab Revenue by Countries (2012-2017)
  5.4.3 South Africa Trastuzumab Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Trastuzumab Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Trastuzumab Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Trastuzumab Sales and Growth Rate (2012-2017)

6 EMEA TRASTUZUMAB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Genentech Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Trastuzumab Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genentech Inc Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Trastuzumab Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Trastuzumab Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Trastuzumab Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abnova Corporation Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 InvivoGen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Trastuzumab Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 InvivoGen Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celltrion
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Trastuzumab Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celltrion Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biocon Limited
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Trastuzumab Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biocon Limited Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bio-Techne
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Trastuzumab Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio-Techne Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 TRASTUZUMAB MANUFACTURING COST ANALYSIS

7.1 Trastuzumab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Trastuzumab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Trastuzumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Trastuzumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA TRASTUZUMAB MARKET FORECAST (2017-2022)

11.1 EMEA Trastuzumab Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Trastuzumab Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Trastuzumab Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Trastuzumab Price and Trend Forecast (2017-2022)
11.2 EMEA Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Trastuzumab Sales Forecast by Type (2017-2022)
11.7 EMEA Trastuzumab Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Trastuzumab
Figure EMEA Trastuzumab Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Trastuzumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Source Product Picture
Figure Animal Source Product Picture
Figure EMEA Trastuzumab Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Trastuzumab by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure EMEA Trastuzumab Market Size (Million USD) by Region (2012-2022)
Figure Europe Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Trastuzumab Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Trastuzumab Revenue (Million USD) Status and Forecast by Countries
Figure Africa Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Trastuzumab Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Trastuzumab Sales Volume and Growth Rate (2012-2022)
Figure EMEA Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Trastuzumab Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Trastuzumab Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Trastuzumab Sales Share by Players (2012-2017)
Figure 2016 Trastuzumab Sales Share by Players
Figure 2017 Trastuzumab Sales Share by Players
Figure EMEA Trastuzumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Trastuzumab Revenue (Million USD) by Players (2012-2017)
Table EMEA Trastuzumab Revenue Share by Players (2012-2017)
Table 2016 EMEA Trastuzumab Revenue Share by Players
Table 2017 EMEA Trastuzumab Revenue Share by Players
Table EMEA Trastuzumab Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Trastuzumab Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Trastuzumab Sales Share by Type (2012-2017)
Figure Sales Market Share of Trastuzumab by Type (2012-2017)
Figure EMEA Trastuzumab Sales Market Share by Type (2012-2017)
Table EMEA Trastuzumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Trastuzumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Trastuzumab by Type in 2016
Table EMEA Trastuzumab Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Trastuzumab Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Trastuzumab Sales Share by Application (2012-2017)
Figure Sales Market Share of Trastuzumab by Application (2012-2017)
Figure EMEA Trastuzumab Sales Market Share by Application in 2016
Table EMEA Trastuzumab Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Trastuzumab Sales Share by Region (2012-2017)
Figure Sales Market Share of Trastuzumab by Region (2012-2017)
Figure EMEA Trastuzumab Sales Market Share in 2016
Table EMEA Trastuzumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Trastuzumab Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Trastuzumab by Region (2012-2017)
Figure EMEA Trastuzumab Revenue Market Share Regions in 2016
Table EMEA Trastuzumab Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Trastuzumab Revenue and Growth Rate (2012-2017)
Table Europe Trastuzumab Sales (K Pcs) by Type (2012-2017)
Table Europe Trastuzumab Market Share by Type (2012-2017)
Figure Europe Trastuzumab Market Share by Type in 2016
Table Europe Trastuzumab Sales (K Pcs) by Application (2012-2017)
Table Europe Trastuzumab Market Share by Application (2012-2017)
Figure Europe Trastuzumab Market Share by Application in 2016
Table Europe Trastuzumab Sales (K Pcs) by Countries (2012-2017)
Table Europe Trastuzumab Sales Market Share by Countries (2012-2017)
Figure Europe Trastuzumab Sales Market Share by Countries (2012-2017)
Figure Europe Trastuzumab Sales Market Share by Countries in 2016
Table Europe Trastuzumab Revenue (Million USD) by Countries (2012-2017)
Table Europe Trastuzumab Revenue Market Share by Countries (2012-2017)
Figure Europe Trastuzumab Revenue Market Share by Countries (2012-2017)
Figure Europe Trastuzumab Revenue Market Share by Countries in 2016
Figure Germany Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Trastuzumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Trastuzumab Sales (K Pcs) by Type (2012-2017)
Table Middle East Trastuzumab Market Share by Type (2012-2017)
Figure Middle East Trastuzumab Market Share by Type (2012-2017)
Table Middle East Trastuzumab Sales (K Pcs) by Applications (2012-2017)
Table Middle East Trastuzumab Market Share by Applications (2012-2017)
Figure Middle East Trastuzumab Sales Market Share by Application in 2016
Table Middle East Trastuzumab Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Trastuzumab Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Trastuzumab Sales Volume Market Share by Countries in 2016
Table Middle East Trastuzumab Revenue (Million USD) by Countries (2012-2017)
Table Middle East Trastuzumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Trastuzumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Trastuzumab Revenue Market Share by Countries in 2016
Figure Saudi Arabia Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Trastuzumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Trastuzumab Sales (K Pcs) by Type (2012-2017)
Table Africa Trastuzumab Sales Market Share by Type (2012-2017)
Figure Africa Trastuzumab Sales Market Share by Type (2012-2017)
Figure Africa Trastuzumab Sales Market Share by Type in 2016
Table Africa Trastuzumab Sales (K Pcs) by Application (2012-2017)
Table Africa Trastuzumab Sales Market Share by Application (2012-2017)
Figure Africa Trastuzumab Sales Market Share by Application (2012-2017)
Table Africa Trastuzumab Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Trastuzumab Sales Market Share by Countries (2012-2017)
Figure Africa Trastuzumab Sales Market Share by Countries (2012-2017)
Figure Africa Trastuzumab Sales Market Share by Countries in 2016
Table Africa Trastuzumab Revenue (Million USD) by Countries (2012-2017)
Table Africa Trastuzumab Revenue Market Share by Countries (2012-2017)
Figure Africa Trastuzumab Revenue Market Share by Countries (2012-2017)
Figure Africa Trastuzumab Revenue Market Share by Countries in 2016
Figure South Africa Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Table Genentech Inc Trastuzumab Basic Information List
Table Genentech Inc Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Inc Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genentech Inc Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Genentech Inc Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Trastuzumab Basic Information List
Table Novartis AG Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Pfizer Trastuzumab Basic Information List
Table Pfizer Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Pfizer Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Abnova Corporation Trastuzumab Basic Information List
Table Abnova Corporation Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Corporation Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abnova Corporation Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Abnova Corporation Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table InvivoGen Trastuzumab Basic Information List
Table InvivoGen Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure InvivoGen Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure InvivoGen Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure InvivoGen Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Celltrion Trastuzumab Basic Information List
Table Celltrion Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltrion Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celltrion Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Celltrion Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Biocon Limited Trastuzumab Basic Information List
Table Biocon Limited Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Limited Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biocon Limited Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Biocon Limited Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Bio-Techne Trastuzumab Basic Information List
Table Bio-Techne Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Techne Trastuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bio-Techne Trastuzumab Sales Market Share in EMEA (2012-2017)
Figure Bio-Techne Trastuzumab Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Trastuzumab
Figure Manufacturing Process Analysis of Trastuzumab
Figure Trastuzumab Industrial Chain Analysis
Table Raw Materials Sources of Trastuzumab Major Manufacturers in 2016
Table Major Buyers of Trastuzumab
Table Distributors/Traders List
Figure EMEA Trastuzumab Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Trastuzumab Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Trastuzumab Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Trastuzumab Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Trastuzumab Sales Market Share Forecast by Region (2017-2022)
Table EMEA Trastuzumab Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Trastuzumab Revenue Market Share Forecast by Region (2017-2022)
Table Europe Trastuzumab Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Trastuzumab Sales Market Share Forecast by Countries (2017-2022)
Table Europe Trastuzumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Trastuzumab Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Trastuzumab Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Trastuzumab Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Trastuzumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Trastuzumab Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Trastuzumab Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Trastuzumab Sales Market Share Forecast by Countries (2017-2022)
Table Africa Trastuzumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Trastuzumab Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Trastuzumab Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Trastuzumab Sales Market Share Forecast by Type (2017-2022)
Table EMEA Trastuzumab Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Trastuzumab Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources